mesothelial protein tagged posts

Engineering T cells to treat pancreatic cancer Researchers hope to have a human version of the T cell in clinical trials this year

Hingorani, a pancreatic cancer specialist, teamed up with Fred Hutch immunotherapy experts Drs. Phil Greenberg and Ingunn Stromnes in successful efforts to breach the cancer’s physical and immunological walls using immunotherapy, a type of treatment that harnesses or refines the body’s own immune system with T-cells engineered to recognize and destroy cancer cells.

Specifically, Hingorani’s team created T cells with a high ffinity to a “relatively” tumor-specific antigen. Why relatively? Notoriously difficult pancreatic tumor cells don’t produce many unique proteins that allow for completely tumor-specific T cells...